A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Inferred to overlap with: Df(3R)ED6255.
Inferred to overlap with: Df(3R)Exel6206.
The presence of P+PBac{XP5.WH5}BSC791 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of the progenitor P{XP}d06753 to be at Release 3 genomic coordinate 22966055 on chromosome arm 3R. This corresponds to Release 5 coordinate 3R:22976690 . The insertion site of the progenitor PBac{WH}CG31077f01593 is Release 5 coordinate 3R:22828504 . Consequently, the breakpoints of Df(3R)BSC791 predicted from the Release 5 genomic coordinates of the transposable element insertion sites are 3R: 22828504;22976690 and the cytological breakpoints predicted from these coordinates are 97D12;97E5.